Long-term safety considerations Available safety data: 40+ years of Russian research and use Thousands of patients in clinical studies Extensive animal safety testing No serious adverse events reported in research Generally recognized as safe in research context Lack of Western data: No large-scale FDA clinical trials Limited peer-reviewed English publications Most data from Russian institutes Skepticism about research quality standards Need international replication Theoretical long-term concerns: Monitoring recommendations: Annual comprehensive physical exam Blood work: CBC, CMP, lipids, inflammatory markers Cancer screening per age-appropriate guidelines Sleep tracking (subjective and objective) Document any changes or concerns Work with peptide-knowledgeable physician Conservative approach: Start with proven 10-day cycles Monitor response carefully Don't exceed recommended dosing Combine with healthy lifestyle View as one tool in longevity strategy Learn about peptide safety at SeekPeptides
AOD9604, on the other hand, hasnt demonstrated the same level of statistically significant outcomes in humans (trial overview)
In a study done with natural bred fish, higher prevalence with O
But after a point-by-point assessment, we determined that Codeage does more to accommodate a larger user population
Doses used clinically generally start modestly and can be adjusted upward based on the patient, with the intravenous route favored precisely because it sidesteps the oral-absorption question
Comparison of thiols, sulfides, disulfides and thiophenes.
